Dr Kevin Kemp
B.Sc.(W.England), M.Sc.(Bristol), Ph.D.(W.England)
Current positions
Research Fellow
Bristol Medical School (THS)
Contact
Media contact
If you are interested in speaking to this expert, contact the University’s Media & PR Team on
Research interests
The major aim of my research is to develop neuro-regenerative therapies for people with currently untreatable progressive neurological disease.
Cell therapies hold much promise for the treatment of human diseases. Experimental findings in both humans and models of neurodegenerative disease have shown that adult stem cells derived from the bone marrow, commonly known as bone marrow or blood stem cells, can protect or even repair injured nerve cells. Through employing experimental studies, ranging from basic neuroscience to translational clinical trials, my research explores the medical use of bone marrow stem cell transplantation and mobilisation techniques as a regenerative therapy for people with Friedreich’s ataxia and cerebellar disorders.
Positions
University of Bristol positions
Research Fellow
Bristol Medical School (THS)
Publications
Recent publications
13/12/2020KIF5A and associated susceptibility genotypes as a novel prognostic biomarker for multiple sclerosis
Journal of Neurology
An open-label pilot study of recombinant granulocyte-colony stimulating factor in Friedreich's ataxia
Nature Communications
Abnormal scaffold attachment factor 1 expression and localisation in spinocerebellar ataxias and huntington’s chorea
Brain Pathology
shRNA-mediated PPARα knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growth
Journal of Pathology
Aberrant cerebellar Purkinje cell function repaired in vivo by fusion with infiltrating bone marrow-derived cells
Acta Neuropathologica